VAGINAL ADENOCARCINOMA
Clinical trials for VAGINAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new VAGINAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for VAGINAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Major trial aims to tame dozens of rare, neglected cancers with immune power combo
Disease control OngoingThis study is testing whether a combination of two immunotherapy drugs (nivolumab and ipilimumab) can help control many different types of rare, advanced cancers that have limited treatment options. It enrolled over 800 adults whose cancer progressed after standard therapy. The g…
Matched conditions: VAGINAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 04, 2026 10:51 UTC
-
Major trial aims to boost survival for advanced gynecologic cancers
Disease control OngoingThis large, late-stage trial is testing whether adding a new drug called triapine to the standard treatment of radiation and chemotherapy (cisplatin) works better for women with newly diagnosed, advanced cervical or vaginal cancer. The goal is to see if the three-drug combination…
Matched conditions: VAGINAL ADENOCARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC